NCT02613923 is a NA clinical trial of GO! To Sleep in Breast Cancer, sponsored by Case Comprehensive Cancer Center.

Who is sponsoring NCT02613923?

NCT02613923 is sponsored by Case Comprehensive Cancer Center.

What drugs are being tested in NCT02613923?

Interventions in NCT02613923: GO! To Sleep, Sleep information, Blood Draw, Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), SF-12 quality of life survey.

What condition does NCT02613923 study?

NCT02613923 studies Breast Cancer, Sleep.

Is NCT02613923 still recruiting?

NCT02613923 is currently completed. Last updated 9 May 2019.

Last reviewed 2019-05-09 · How we verify

NCT02613923

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer

Completed NA Last updated 9 May 2019

What this trial tests

NA trial testing GO! To Sleep in Breast Cancer in 17 participants. Completed in 23 July 2017.

Timeline

4 August 2015

Primary endpoint
23 March 2017

23 July 2017

Quick facts

Lead sponsor	Case Comprehensive Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	17
Start date	4 August 2015
Primary completion	23 March 2017
Estimated completion	23 July 2017
Sites	1 location across United States

Drugs / interventions tested

GO! To Sleep
Sleep information
Blood Draw — full drug profile →
Pittsburgh Sleep Quality Index (PSQI)
Insomnia Severity Index (ISI)
SF-12 quality of life survey

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Sleep — all drugs for Sleep →

Sponsor

Case Comprehensive Cancer Center — full company profile →

Who can join

21 and older, female only, with Breast Cancer or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer. Participants are asked to participate in this research study because they have been identified as being at higher than average risk of developing breast cancer. The purpose of this study is to compare women who get a sleep intervention to women who do not get a sleep intervention. This study team will compare these two groups of women to see if the sleep intervention improves their sleep and if it lowers markers of inflammation that have been associated with an increased risk of breast cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Case Comprehensive Cancer Center trials

Trials by the same sponsor.

NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
NCT07167056 — Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer · NA · recruiting
NCT07084779 — Investigation of Impact of AI on Prostate Cancer Workflow · NA · recruiting
NCT06904482 — Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · Phase 2 · recruiting
NCT07044362 — Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02613923 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Case Comprehensive Cancer Center
Last refreshed: 9 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02613923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing